A randomized trial to evaluate the effects of a supervised exercise program on insomnia in patients with non-metastatic breast cancer undergoing chemotherapy: design of the FATSOMCAN study
Abstract Background Up to 70% of breast cancer patients report symptoms of insomnia during and after treatment. Despite the ubiquity of insomnia symptoms, they are under-screened, under-diagnosed and poorly managed in breast cancer patients. Sleep medications treat symptoms but are ineffective to cu...
Main Authors: | Chloé Drozd, Elsa Curtit, Quentin Jacquinot, Charlène Marquine, Laura Mansi, Loïc Chaigneau, Erion Dobi, Julien Viot, Guillaume Meynard, Marie-Justine Paillard, Morgan Goujon, Pauline Roux, Dewi Vernerey, Valérie Gillet, Hubert Bourdin, Silvio Galli, Nathalie Meneveau, Fabienne Mougin |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-05-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12885-023-10902-6 |
Similar Items
-
Cardiotoxicity is mitigated after a supervised exercise program in HER2-positive breast cancer undergoing adjuvant trastuzumab
by: Quentin Jacquinot, et al.
Published: (2022-09-01) -
Eszopiclone versus zopiclone in the treatment of insomnia
by: Luciano Ribeiro Pinto Jr, et al.
Published: (2016-01-01) -
Comparison of two assessment tools that measure insomnia: The insomnia severity index and polysomnography
by: Khosro Sadeghniiat-Haghighi, et al.
Published: (2014-01-01) -
Similar polysomnographic pattern in primary insomnia and major depression with objective insomnia: a sign of common pathophysiology?
by: Matthieu Hein, et al.
Published: (2017-07-01) -
Systemic high-dose intravenous methotrexate in patients with central nervous system metastatic breast cancer
by: F. Bazan, et al.
Published: (2019-11-01)